EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

FOXM1 influences DNA methylation to augment TACC3 alternative splicing directed by KAT2A in hepatocellular carcinoma

Li Na Zhao, Jesper B Andersen

Clinical and Molecular Hepatology · 2026

DOI: 10.3350/cmh.2025.1370 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Molecular Hepatology, 2026. Verfasst von Li Na Zhao und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health and Medical Sciences, Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Forkhead Box Protein M1, Liver Neoplasms, Alternative Splicing, Carcinoma, Hepatocellular. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Novo Nordisk Foundation, Danish Cancer Society, Independent Research Fund Denmark for Medical Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Aims: Hepatocellular carcinoma (HCC) is characterized by profound transcriptomic dysregulation, yet the mechanism(s) by which DNA methylation is coordinated with chromatin modifications to regulate alternative splicing during tumorigenesis remains poorly understood.

Methods

Using prospectively paired multi-omics data obtained from metabolic dysfunction-associated steatotic liver disease (MASLD)-HCC patients and coupled with a premalignant MASLD cohort, we have uncovered a previously unrecognized gene-regulatory axis centered on TACC3 isoform-switching.

Results

In the non-tumoral context, the TACC3-201 isoform directly engages the histone acetyltransferase KAT2A to coordinate the regulation of NOTCH4 signaling. In HCC, this regulatory axis is disrupted whereby FOXM1 overrides DNMT1-mediated methylation, upregulating TACC3, and decoupling TACC3 from the KAT2A-associated NOTCH4 co-expression module. This rewiring is licensing tumor-specific cell-cycle progression and epigenetic plasticity. Thus, FOXM1 reshapes the TACC3-KAT2A interaction, while DNMT1 drives context-dependent DNA methylation, activating the CDK1-inhibitory kinase PKMYT1.

Conclusions

We uncovered TACC3-KAT2A as an emerging regulatory axis caused by alternative splicing in HCC and propose FOXM1-driven TACC3 inhibition to synergistically disrupt mitotic fidelity and transcriptional regulation, potentially offering new therapeutic avenues for HCC with reduced toxicity to the normal liver.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Forkhead Box Protein M1Liver NeoplasmsAlternative SplicingCarcinoma, HepatocellularDNA MethylationHistone AcetyltransferasesMicrotubule-Associated ProteinsHumansSignal TransductionGene Expression Regulation, NeoplasticDNA (Cytosine-5-)-Methyltransferase 1Cell Line, TumorProtein Isoforms

Stichwörter der Autor:innen

Alternative splicingFOXM1Hepatocellular carcinomaKAT2ATACC3

Substanzen

Forkhead Box Protein M1Histone AcetyltransferasesMicrotubule-Associated ProteinsFOXM1 protein, humanDNA (Cytosine-5-)-Methyltransferase 1DNMT1 protein, humanProtein Isoforms

Autor:innen und Institutionen

  • Department of Health and Medical Sciences, Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark.

Förderung

  • Novo Nordisk Foundation
  • Danish Cancer Society
  • Independent Research Fund Denmark for Medical Research

Zitieren

APA

Zhao, L. N., & Andersen, J. B. (2026). FOXM1 influences DNA methylation to augment TACC3 alternative splicing directed by KAT2A in hepatocellular carcinoma. Clinical and Molecular Hepatology. https://doi.org/10.3350/cmh.2025.1370

Vancouver

Zhao LN, Andersen JB. FOXM1 influences DNA methylation to augment TACC3 alternative splicing directed by KAT2A in hepatocellular carcinoma. Clinical and Molecular Hepatology. 2026. doi:10.3350/cmh.2025.1370

BibTeX
@article{Zhao2026,
  author = {Zhao, Li Na and Andersen, Jesper B},
  title = {FOXM1 influences DNA methylation to augment TACC3 alternative splicing directed by KAT2A in hepatocellular carcinoma},
  journal = {Clinical and Molecular Hepatology},
  year = {2026},
  doi = {10.3350/cmh.2025.1370}
}
Kostenlos starten →